Seldin, David C <br/><br/>
Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation.  [electronic resource] 

 -  Blood  Sep 2004 
 - 1888-93 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Standard No.: </label>10.1182/blood-2004-01-0089  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amyloidosis--drug therapy<br/>Follow-Up Studies<br/>Health Surveys<br/>Humans<br/>Melphalan--administration & dosage<br/>Middle Aged<br/>Quality of Life<br/>Stem Cell Transplantation<br/>Surveys and Questionnaires<br/>Survival Rate<br/>Treatment Outcome